Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration ...

The US Food and Drug Administration ... last year after an FDA advisory committee declared that it was ineffective. Other ...

All impacted products have now been given a Class II recall classification by the U.S. Food and Drug Administration (FDA). A Class II recall is "a situation in which use of or exposure to a ...

The U.S. Food and Drug Administration has proposed ... For now, companies may continue to market drug products containing oral phenylephrine as a nasal decongestant. The FDA will also start seeking ...

Glucomannan: A soluble fiber derived from the root of the konjac plant, Glucomannan expands in the stomach, promoting a ...

RoxyBond, a Schedule II full opioid agonist, utilizes proprietary abuse-deterrent technology to prevent misuse and abuse.

Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...

In general, when a person prepares for a surgery, the guidance is to fast before going under anesthesia– but for patients, on gGLP-1's there may still be gastric juices, in the stomach, since the ...

FIRST ON THE DAILY SIGNAL—The emergency room visitation rate for abortion complications appears to have increased since the U.S. Food ... FDA from requiring that mifepristone, or the abortion ...

It was added to cold and flu remedies in the 1990s when another ingredient went behind the counter over illicit meth lab concerns.

(WXYZ) — The Food and Drug Administration has updated labels for popular weight loss drugs like Ozempic and Wegovy. A new ...